Ticagrelor versus Adjusted‐Dose Prasugrel in Acute Coronary Syndrome with Percutaneous Coronary Intervention

Dual antiplatelet therapy (DAPT) with ticagrelor or adjusted‐dose prasugrel has been used for acute coronary syndrome (ACS). However, few studies have directly compared these two drugs. In this study, we compared the real‐world applications and outcomes of these two drugs in patients with ACS who ha...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Clinical pharmacology and therapeutics Ročník 116; číslo 3; s. 747 - 756
Hlavní autoři:	Tsai, Ming‐Lung, Lin, Yuan, Chen, Dong‐Yi, Lin, Ming‐Shyan, Wang, Chao‐Yung, Hsieh, I‐Chang, Yang, Ning‐I, Hung, Ming‐Jui, Chen, Tien‐Hsing
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 01.09.2024
Témata:	Acute Coronary Syndrome - drug therapy Acute Coronary Syndrome - therapy Aged Female Hemorrhage - chemically induced Hemorrhage - epidemiology Humans Male Middle Aged Percutaneous Coronary Intervention - adverse effects Platelet Aggregation Inhibitors - administration & dosage Platelet Aggregation Inhibitors - adverse effects Platelet Aggregation Inhibitors - therapeutic use Prasugrel Hydrochloride - administration & dosage Prasugrel Hydrochloride - adverse effects Prasugrel Hydrochloride - therapeutic use Retrospective Studies Ticagrelor - administration & dosage Ticagrelor - adverse effects Ticagrelor - therapeutic use Treatment Outcome
ISSN:	0009-9236, 1532-6535, 1532-6535
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!